{
    "url_original": "https://www.wsj.com/articles/former-allergan-ceos-spac-agrees-to-1-1-billion-merger-with-hydrafacial-co-11607466475?mod=business_minor_pos1",
    "url": "former-allergan-ceos-spac-agrees-to-1-1-billion-merger-with-hydrafacial-co-11607466475",
    "title": "Former Allergan CEO’s SPAC Agrees to $1.1 Billion Merger With Beauty Products Company",
    "sub_head": "HydraFacial’s private-equity owners, Linden Capital Partners and DW Healthcare Partners, will retain a combined 25% stake in the business following the merger",
    "category_1": "Pro PE Exits",
    "image_1_url": "https://images.wsj.net/im-270272?width=620&size=1.5",
    "image_1": "im-270272.jpg",
    "time": "2020-12-08 17:27:00",
    "body": "A blank-check company backed by former Allergan PLC Chief Executive Brent Saunders is set to merge with a private equity-backed health and beauty company in a deal valued at $1.1 billion.<br />Mr. Saunders’ vehicle,  Vesper Healthcare Acquisition Corp. ,  is set to combine with the HydraFacial Co., a producer of skin-care products and treatments sold by beauty retailers, spas and dermatology clinics. Once completed, the deal will take the private equity-owned company onto the public market.<br />HydraFacial, of Long Beach, Calif., has been owned by health care-focused firms Linden Capital Partners and DW Healthcare Partners since December 2016. Both firms will maintain a combined 25% stake in the business and each will retain a board seat upon closure of the deal, expected in the first half of 2021.<br />Vesper will pay $975 million for the company, with up to an additional $75 million to be paid if HydraFacial completes specific prospective acquisitions it has identified.<br />As part of the deal, a group of institutional investors that includes Fidelity Management & Research Co., Redmile Group LLC, Principal Global Investors LLC, Camber Capital Management LP and Woodline Partners Ltd. are contributing $350 million in the form of a private common stock purchase."
}